Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Dyrhol Riise, Anne M ^a   Gran, Gerd ^a   Wenzel Larsen, Tore ^a   Blomberg, Bjørn ^a,b   Haanshuus, Christel G ^a   Mørkve, Odd ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HUMAN; IMMIGRATION; INFECTION RISK; LATENT TUBERCULOSIS; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS; AMBULATORY CARE; ANIMAL; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DRUG MONITORING; EVALUATION; IMMUNOASSAY; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANIMALS; ANTITUBERCULAR AGENTS; CHILD; CLINICAL LABORATORY TECHNIQUES; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; ISONIAZID; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRES; RADIOGRAPHY, THORACIC; RIFAMPIN; RISK FACTORS; SPUTUM; YOUNG ADULT;

EID: 77951242451     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-57     Document Type: Article

References (58)

1. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005, 172:631-5. 10.1164/rccm.200502-196OC, 15961696.
2. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003, 361:1168-73. 10.1016/S0140-6736(03)12950-9, 12686038.
3. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001, 163:824-8.
4. Ravn P, Munk ME, Andersen AB, et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clinical and Diagnostic Laboratory Immunology 2005, 12:491-6. 1074386, 15817755.
5. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004, 170:65-9. 10.1164/rccm.200402-232OC, 15087297.
6. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Annals of Internal Medicine 2008, 149:177-84.
7. Winje B, Oftung F, Mannsåker T, Dyrhol-Riise AM. Nye immunologiske blodtester for påvisning av tuberkulosesmitte (New immunological blood based assays for detection of tuberculosis. A report from the Infectious Disease Control Register) (Norwegian). MSIS-rapport 2007, 35:10.
8. Drobniewski F, Cobelens FJ-PZ. Use of Gamma-interferon assays in low- and medium-prevalence countries in Europe: a consensus statement of a Wolfheze Workshop organised by KNCV/EuroTB. Vilnius Sept 2006. (Eurosurveillance weekly) 2007, 12.
9. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006, 367:1328-34. 10.1016/S0140-6736(06)68579-6, 16631911.
10. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006, 174:349-55. 10.1164/rccm.200604-472OC, 2648116, 16690977.
11. Ponce D, Acevedo-Vasquez E, Alvizuri S, et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 2008, 35:776-81.
12. Kaushik VV, Ambalavanan S, Binymin K. Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience. Rheumatology (Oxford) 2007, 46:1863-4. 10.1093/rheumatology/kem252, 17965441.
13. Chee CBE, KhinMar KW, Gan SH, Barkham TMS, Pushparani M, Wang YT. Latent tuberculosis infection treatment and T-Cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 2007, 175:282-7. 10.1164/rccm.200608-1109OC, 17082492.
14. Higuchi K, Harada N, Mori T. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology 2008, 13:468-72. 10.1111/j.1440-1843.2008.01244.x, 18399875.
15. Pai M, Joshi R, Dogra S, et al. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol 2006, 1:7. 10.1186/1745-6673-1-7, 1481589, 16722616.
16. Pollock NR, Kashino SS, Napolitano DR, et al. Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results. Infect Control Hosp Epidemiol 2009, 30:392-5. 10.1086/596606, 19236281.
17. Diel R, Wrighton-Smith P, Zellweger JP. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. European Respiratory Journal 2007, 30:321-32. 10.1183/09031936.00145906, 17504793.
18. Wrighton-Smith P, Zellweger JP. Direct costs of three models for the screening of latent tuberculosis infection. European Respiratory Journal 2006, 28:45-50. 10.1183/09031936.06.00005906, 16611659.
19. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008, 177:1164-70. 10.1164/rccm.200711-1613OC, 18276940.
20. Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. European Respiratory Journa 2009, 33:956-73.
21. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. International Journal of Tuberculosis and Lung Disease 2006, 10:1192-204.
22. Myrvang B. Mycobacterial infections in Norway. Scand J Infect Dis Suppl 1995, 98:12-4.
23. Folkehelseinstituttet Tuberkulose i Norge 2006 (Tuberculosis in Norway, 2006. A report from the Infectious Disease Control Register) (Norwegian). MSIS-report 2007, 35:16. Folkehelseinstituttet.
24. Winje BA, Mannsåker T, Heldal E, Dahle UR. Forebygging og kontroll av tuberkulose, en veileder (Norwegian) [Guidelines for prevention and control of tuberculosis]. 2002, Oslo: Nasjonalt Folkehelseinstitutt, 7.
25. Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA. Comparison of QuantiFERON-TB Gold In-Tube Test and Tuberculin Skin Test for Identification of Latent Mycobacterium tuberculosis Infection in Healthcare Staff and Association Between Positive Test Results and Known Risk Factors for Infection. Infection Control and Hospital Epidemiology 2009, 30:215-21. 10.1086/595695, 19191484.
26. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M-tuberculosis specific interferon-gamma test. Respiratory Research 2006, 7:56. 10.1186/1465-9921-7-56, 1523341, 16579856.
27. Winje BA, Oftung F, Korsvold GE, et al. Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of QuantiFERON (R) TB Gold with tuberculin skin test. BMC Infectious Diseases 2008, 8:65. 10.1186/1471-2334-8-65, 2405787, 18479508.
28. Storla DG, Kristiansen I, Oftung F, et al. Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure. BMC Infectious Diseases 2009, 9:60. 10.1186/1471-2334-9-60, 2690599, 19432995.
29. Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 2007, 14:880-5. 10.1128/CVI.00132-07, 1951056, 17507543.
30. Infuso A, Falzon D. European survey of BCG vaccination policies and surveillance in children, 2005. Euro Surveill 2006, 11:6-11.
31. Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007, 131:1424-34. 10.1378/chest.06-2728, 17494792.
32. Carvalho ACC, Pezzoli MC, El Hamad I, et al. QuantiFERON (R)-TB Gold test in the identification of latent tuberculosis infection in immigrants. Journal of Infection 2007, 55:164-8. 10.1016/j.jinf.2007.02.004, 17428542.
33. Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respiratory Research 2006, 17(7):77.
34. Nienhaus A, Schablon A, Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection--analysis of discordant results, when compared to the tuberculin skin test. PLoS One 2008, 3:e2665. 10.1371/journal.pone.0002665, 2441828, 18628829.
35. Bahrmand AR, Madani H, Samar G, et al. Detection and identification of non-tuberculous mycobacterial infections in 6,472 tuberculosis suspected patients. Scand J Infect Dis 1996, 28:275-8. 10.3109/00365549609027172, 8863361.
36. Stead WW. Why Does Tuberculosis Remain So Common Among the Elderly. Hospital Practice 1987, 22:9, 13.
37. Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987, 107:837-42.
38. Mahomed H, Hughes EJ, Hawkridge T, et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. International Journal of Tuberculosis and Lung Disease 2006, 10:310-6.
39. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India - Comparison of a whole-blood interferon gamma assay with tuberculin skin testing. Journal of the American Medical Association 2005, 293:2746-55. 10.1001/jama.293.22.2746, 15941804.
40. Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007, 175:618-27. 10.1164/rccm.200608-1099OC, 17170386.
41. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. Journal of the American Medical Association 2005, 293:2756-61. 10.1001/jama.293.22.2756, 15941805.
42. Thompson NJ, Glassroth JL, Snider DE, Farer LS. The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 1979, 119:587-97.
43. Vekemans J, Lienhardt C, Sillah JS, et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001, 69:6554-7. 10.1128/IAI.69.10.6554-6557.2001, 98797, 11553606.
44. Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001, 167:5217-25.
45. Al Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P. Restoration of mycobacterial antigen-induced proliferation and interferon-[gamma] responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunology and Medical Microbiology 2003, 38:249-56. 10.1016/S0928-8244(03)00166-4, 14522460.
46. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clinical Infectious Diseases 2004, 38:754-6. 10.1086/381754, 14986262.
47. Ferrand RA, Bothamley GH, Whelan A, Dockrell HM. Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis 2005, 9:1034-9.
48. Pai M, Joshi R, Bandyopadhyay M, et al. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 2007, 35:98-103. 10.1007/s15010-007-6114-z, 17401714.
49. Dheda K, Pooran A, Pai M, et al. Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. Journal of Infection 2007, 55:169-73. 10.1016/j.jinf.2007.02.005, 17448540.
50. Dominguez J, Souza-Galvao M, Ruiz-Manzano J, et al. T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagnostic Microbiology and Infectious Disease 2009, 63:43-51. 10.1016/j.diagmicrobio.2008.09.010, 19026511.
51. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON-TB Gold In-Tube (R) test to monitor treatment efficacy in active pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease 2008, 12:1146-52.
52. Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infectious Diseases 2009, 9:23. 10.1186/1471-2334-9-23, 2651889, 19250549.
53. Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted?. Trends Mol Med 2007, 13:175-82. 10.1016/j.molmed.2007.03.004, 17418641.
54. Perry S, Sanchez L, Yang SF, Agarwal Z, Hurst P, Parsonnet J. Reproducibility of QuantiFERON-TB gold in-tube assay. Clinical and Vaccine Immunology 2008, 15:425-32. 10.1128/CVI.00398-07, 2268272, 18199741.
55. Veerapathran A, Joshi R, Goswami K, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS One 2008, 3:e1850. 10.1371/journal.pone.0001850, 2266993, 18365006.
56. Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 2008, 133:1415-20. 10.1378/chest.07-2193, 18347207.
57. Leyten EM, Prins C, Bossink AW, et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J 2007, 29:1212-6. 10.1183/09031936.00117506, 17215314.
58. Zyl-Smit RN, Pai M, Peprah K, et al. Within-Subject Variability and Boosting of T-Cell Interferon-gamma Responses after Tuberculin Skin Testing. Am J Respir Crit Care Med 2009, 180:49-58. 10.1164/rccm.200811-1704OC, 19342414.